Clinical Trial to Evaluate the Safety and Immunogenicity in Age De-Escalation of Direct Venous Inoculation of a Plasmodium Falciparum Sporozoite Vaccine in Tanzanian Adults, Children, and Infants

Trial Profile

Clinical Trial to Evaluate the Safety and Immunogenicity in Age De-Escalation of Direct Venous Inoculation of a Plasmodium Falciparum Sporozoite Vaccine in Tanzanian Adults, Children, and Infants

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 27 Apr 2017

At a glance

  • Drugs Malaria vaccine live attenuated-Sanaria (Primary)
  • Indications Malaria
  • Focus Adverse reactions
  • Sponsors Sanaria
  • Most Recent Events

    • 24 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 Jun 2017.
    • 12 Oct 2016 Planned End Date changed from 1 Sep 2016 to 1 Mar 2017.
    • 20 Jul 2016 Planned End Date changed from 1 Dec 2016 to 1 Sep 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top